NCT03193216View on ClinicalTrials.gov

The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Barretts Esophagus With Dysplasia
Interventions
DRUG

Alginates

Liquid Alginate therapy will be added to twice daily PPI regimen. Patients will be asked to take the alginate solution four times daily (following meals and at bedtime) at 10ml/dose.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03193216 - The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus | Biotech Hunter | Biotech Hunter